Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire. [electronic resource]
Producer: 20170529Description: 1732-9 p. digitalISSN:- 1534-6080
- Adolescent
- Adult
- Antilymphocyte Serum -- adverse effects
- Bone Marrow Transplantation -- methods
- Busulfan -- therapeutic use
- Chi-Square Distribution
- Chronic Disease
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Dose Fractionation, Radiation
- Female
- France
- Graft vs Host Disease -- immunology
- HLA Antigens -- immunology
- Histocompatibility
- Histocompatibility Testing
- Humans
- Immunosuppressive Agents -- adverse effects
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- diagnosis
- Male
- Middle Aged
- Multivariate Analysis
- Myeloablative Agonists -- therapeutic use
- Myelodysplastic Syndromes -- diagnosis
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- Proportional Hazards Models
- Recurrence
- Retrospective Studies
- Risk Factors
- Time Factors
- Transplantation Conditioning -- adverse effects
- Treatment Outcome
- Unrelated Donors
- Whole-Body Irradiation
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.